Scholars@Duke publication: Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences?

Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences?

Conferences

Miller, KL; Marks, LB; Bentley, RC; Clough, RW; Prosnitz, RG; Leight, GS

Published in: BREAST CANCER RESEARCH AND TREATMENT

December 2002

BREAST CANCER RESEARCH AND TREATMENT

0167-6806

December 2002

S61 / S61

APA

Chicago

ICMJE

MLA

NLM

Miller, K. L., Marks, L. B., Bentley, R. C., Clough, R. W., Prosnitz, R. G., & Leight, G. S. (2002). Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences? In BREAST CANCER RESEARCH AND TREATMENT (Vol. 76, pp. S61–S61).

Miller, K. L., L. B. Marks, R. C. Bentley, R. W. Clough, R. G. Prosnitz, and G. S. Leight. “Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences?” In BREAST CANCER RESEARCH AND TREATMENT, 76:S61–S61, 2002.

Miller KL, Marks LB, Bentley RC, Clough RW, Prosnitz RG, Leight GS. Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences? In: BREAST CANCER RESEARCH AND TREATMENT. 2002. p. S61–S61.

Miller KL, Marks LB, Bentley RC, Clough RW, Prosnitz RG, Leight GS. Does increased sectioning of ductal carcinoma in-situ (DCIS) pathologic specimens have clinical consequences? BREAST CANCER RESEARCH AND TREATMENT. 2002. p. S61–S61.

BREAST CANCER RESEARCH AND TREATMENT

0167-6806

December 2002

S61 / S61